Meronem 1000 mg Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Meronem 1000 mg Injection contains meropenem, a broad-spectrum carbapenem antibiotic. Its labelling describes it for the treatment of severe bacterial infections — including infections of the skin, brain (meningitis), lungs, abdomen, blood, and urinary tract — in patients admitted to hospital. It is described as killing the bacteria that cause infection by stopping them from building their protective cell wall, and it does not treat viral infections.

Active ingredient
Meropenem (as trihydrate)
Strength
1000 mg
Dosage form
Powder for solution for injection or infusion
Therapeutic class
Carbapenem antibiotic (broad-spectrum)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with meropenem and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of severe bacterial infections of the skin, brain (meningitis), lungs, abdomen, blood, and urinary tract
  • Described for the prevention of infection after surgery of the colon or rectum
  • Described as killing bacteria by preventing them from building their protective cell wall
  • Described as not effective against viral infections
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Administered only by a doctor or nurse as a drip, infusion, or direct injection into a vein — not self-administered
  • The dose and duration are set by the doctor according to the condition
  • The full course should be completed, even if the patient feels better

Described Side Effects

Commonly described side effects include:

  • Rash and itching
  • Headache
  • Nausea and vomiting
  • Diarrhoea
  • Constipation
  • Injection-site inflammation
  • Anaemia (low number of red blood cells)

These are described as commonly temporary. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • The doctor should be told about any liver or kidney problems, any allergy to antibiotics, or any history of seizures
  • Its labelling describes it as suitable for use in pregnancy and breastfeeding, though this should be confirmed with the treating clinician
  • The full course should be completed to reduce the risk of the infection returning
  • Any persistent or severe side effect should be reviewed by a clinician

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains meropenem, a broad-spectrum carbapenem antibiotic used to treat severe bacterial infections of the skin, brain, lungs, abdomen, blood, and urinary tract in hospitalised patients, and to prevent infection after colorectal surgery. It does not treat viral infections. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling states it is administered by a doctor or nurse as a drip, infusion, or direct injection into a vein, at the dose and duration set by the doctor. It is not self-administered, and the full course should be completed.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services